Nua raises $50M Series C to scale women's wellness platform in India 🌸
Mumbai-based Nua has raised $50M in a Series C led by Peak XV and Filter Capital, with existing investors Mirabilis Investment Trust and Footpath Ventures also participating. The round includes both primary and secondary components. Founded in 2017, Nua sells period care, maternity care and intimate care products across online and physical retail channels, and runs a period-tracking app and an anonymous women's health chat service. The company has grown its annualised revenue run rate from ₹100 crore to ₹500 crore in 24 months while remaining profitable, and now serves more than three million women and girls every month.
FDA grants accelerated approval to AstraZeneca's Etcamah for ESR1-mutated metastatic breast cancer 💊
The FDA has granted accelerated approval to Etcamah (camizestrant) for adults with HR-positive, HER2-negative locally advanced or metastatic breast cancer with an ESR1 mutation detected during aromatase inhibitor and CDK4/6 inhibitor therapy. Used in combination with a CDK4/6 inhibitor, Etcamah demonstrated a median progression-free survival of 16 months versus 9.2 months on continued aromatase inhibitor therapy. Notably, this is the first FDA approval of a cancer therapy guided by ctDNA detection of a resistance mutation before imaging confirms disease progression - though confirmatory studies are required to verify clinical benefit. The Guardant360 CDx assay was also authorised as a companion diagnostic.
“Women living with metastatic breast cancer face an uphill battle as their tumors continuously evolve to escape treatment. We owe them every weapon in our arsenal. Today’s approval delivers a win to these patients by granting them a targeted therapy designed specifically to overcome resistance, giving them more time before their disease progresses.”
— Kyle Diamantas, Acting Commissioner, FDA
DNB launches what it describes as the world's first women's health equity fund 💰
Norwegian bank DNB has launched "DNB Fund Women's Health," an actively managed global equity fund investing exclusively in companies with documented relevance to women's health, led by portfolio manager and physician Anesa Mulabecirovic Sahnoun. The fund will hold 35 to 50 companies spanning pharma, diagnostics, medtech, health services and consumer health. DNB says it is the first fund of its kind globally.
“As far as we know, this is the first equity fund in the world that only invests in companies with relevance for women’s health. My view is that women’s health is an investment category, and that you can make money from it"
— Anesa Mulabecirovic Sahnoun, Portfolio Manager and Physician, DNB Fund Women’s Health
The Fertility Partners sells US clinic Illume Fertility to IVI RMA 🧬
Canada's largest fertility network, The Fertility Partners, has sold Illume Fertility - serving patients across Connecticut and New York - to IVI RMA North America, with the transaction closing on 3 September. TFP described the sale as a deliberate portfolio decision to focus capital and leadership attention on building the leading fertility network in Canada. Illume will continue operating under IVI RMA, offering IVF, fertility preservation and third-party reproduction. The deal reflects broader consolidation in reproductive medicine, with global players expanding US footprints while regional networks sharpen their home-market focus.
"For TFP, this is about focus. Our strongest opportunities are here in Canada, and this transaction allows us to put our full attention on building the leading fertility network in the country."
— Heather Stark, CEO, The Fertility Partners
Aunt Martha's Health & Wellness secures $3M grant to fund new purpose-built women's health clinic in Chicago Heights 🏥
Aunt Martha's Health & Wellness has been awarded nearly $3M through the Illinois Capital Development Board's Community Health Center Construction Grant Program to replace its Women's Health Center in Chicago Heights with a new, purpose-built 5,375 sq ft facility. The clinic will support obstetric and gynaecologic care, family planning, reproductive health, behavioural health and telehealth services. The site has served 35,000 patients through 141,000 visits since 2016. Aunt Martha's was the only South Suburban Cook County health centre selected in this round of the state's $50M capital programme.
"Fifty years ago, Aunt Martha's made a decision to stand behind young people and families who needed access to care, even when doing so was not easy. This investment allows us to carry that commitment forward in a new way."
— Raul Garza, President and CEO, Aunt Martha's Health & Wellness
Ananya Health lands $100K to advance portable cervical cancer prevention device toward FDA clearance 🔬
EHA Impact Ventures has made its third follow-on investment in Ananya Health - a $100K seed follow-on to advance the company's battery-powered cryoablation device toward FDA 510(k) clearance by mid-2027. Unlike traditional cryoablation, Ananya's device is portable, affordable and usable by clinicians who already perform pelvic exams - designed to work equally for a midwife in Nairobi and an OB-GYN in Chicago.
"Every clinical milestone we've hit has been built on the assumption that this device needs to work for a midwife in Nairobi and an OB-GYN in Chicago alike. EIV's reinvestment moves us closer to FDA clearance."
— Anu Parvatiyar, CEO, Ananya Health
